Tags

Type your tag names separated by a space and hit enter

Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.
Clin Ther. 2008 Sep; 30(9):1629-38.CT

Abstract

BACKGROUND

Midodrine is an alpha-agonist prodrug of desglymidodrine (DGM) that has been reported to be of clinical benefit in patients with neurocardiogenic syncope. Its effects may be mediated not only by its hypertensive properties but also by its neurohumoral influences independent of blood pressure (BP).

OBJECTIVE

The present study aimed to simultaneously characterize the effects of midodrine on BP, plasma catecholamines, plasma atrial natriuretic peptide (ANP), and power spectral analysis of heart rate (HR) in healthy volunteers.

METHODS

This was a prospective, randomized, single-blind, 2-period, crossover study in which a single, oral, 5-mg dose of midodrine was compared with placebo. The washout period between midodrine and placebo was 1 week. The study parameters included plasma DGM (as measured by high-performance liquid chromatography [HPLC]); systolic and diastolic BP (as measured with an oscillometric monitor); HR; plasma catecholamines (measured by HPLC); plasma ANP, also known as venous return (measured by a radio-immunoassay); and low- and high-frequency HR variation (calculated from computerized 5-minute electrocardiographic recordings). All study parameters were measured simultaneously 12 times just before and over a period of 8 hours after drug administration.

RESULTS

Fifteen healthy nonsmoking male subjects (14 white, 1 black; mean [SD] age, 28.6 [4.7] years; weight, 74.5 [16.4] kg; seated BP, 109.9 [9.0]/73.6 [9.5] mm Hg; seated HR, 63.8 [8.4] bpm) were randomized. No significant effects of midodrine on BP were observed. At Cmax, midodrine decreased norepinephrine from 188.4 (30.6) to 162.5 (29.8) pg/mL (P = 0.011) and HR from 57.2 (7.3) to 54.9 (6.6) bpm (P = 0.022). A significant correlation was found between DGM concentration and HR (varphi -0.61; P = 0.014). A DGM-related increase in plasma ANP (+29.6 [90.0] fmoL/mL) was observed.

CONCLUSION

This study in healthy male volunteers found that midodrine has sympatholytic influences that are independent of BP but related to augmented venous return.

Authors+Show Affiliations

Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada. maxime.lamarre-cliche@ircm.qc.caNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18840368

Citation

Lamarre-Cliche, Maxime, et al. "Pharmacokinetic and Pharmacodynamic Effects of Midodrine On Blood Pressure, the Autonomic Nervous System, and Plasma Natriuretic Peptides: a Prospective, Randomized, Single-blind, Two-period, Crossover, Placebo-controlled Study." Clinical Therapeutics, vol. 30, no. 9, 2008, pp. 1629-38.
Lamarre-Cliche M, Souich Pd, Champlain Jd, et al. Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study. Clin Ther. 2008;30(9):1629-38.
Lamarre-Cliche, M., Souich, P. d., Champlain, J. d., & Larochelle, P. (2008). Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study. Clinical Therapeutics, 30(9), 1629-38. https://doi.org/10.1016/j.clinthera.2008.09.001
Lamarre-Cliche M, et al. Pharmacokinetic and Pharmacodynamic Effects of Midodrine On Blood Pressure, the Autonomic Nervous System, and Plasma Natriuretic Peptides: a Prospective, Randomized, Single-blind, Two-period, Crossover, Placebo-controlled Study. Clin Ther. 2008;30(9):1629-38. PubMed PMID: 18840368.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study. AU - Lamarre-Cliche,Maxime, AU - Souich,Patrick du, AU - Champlain,Jacques de, AU - Larochelle,Pierre, PY - 2008/06/20/accepted PY - 2008/10/9/pubmed PY - 2009/1/7/medline PY - 2008/10/9/entrez SP - 1629 EP - 38 JF - Clinical therapeutics JO - Clin Ther VL - 30 IS - 9 N2 - BACKGROUND: Midodrine is an alpha-agonist prodrug of desglymidodrine (DGM) that has been reported to be of clinical benefit in patients with neurocardiogenic syncope. Its effects may be mediated not only by its hypertensive properties but also by its neurohumoral influences independent of blood pressure (BP). OBJECTIVE: The present study aimed to simultaneously characterize the effects of midodrine on BP, plasma catecholamines, plasma atrial natriuretic peptide (ANP), and power spectral analysis of heart rate (HR) in healthy volunteers. METHODS: This was a prospective, randomized, single-blind, 2-period, crossover study in which a single, oral, 5-mg dose of midodrine was compared with placebo. The washout period between midodrine and placebo was 1 week. The study parameters included plasma DGM (as measured by high-performance liquid chromatography [HPLC]); systolic and diastolic BP (as measured with an oscillometric monitor); HR; plasma catecholamines (measured by HPLC); plasma ANP, also known as venous return (measured by a radio-immunoassay); and low- and high-frequency HR variation (calculated from computerized 5-minute electrocardiographic recordings). All study parameters were measured simultaneously 12 times just before and over a period of 8 hours after drug administration. RESULTS: Fifteen healthy nonsmoking male subjects (14 white, 1 black; mean [SD] age, 28.6 [4.7] years; weight, 74.5 [16.4] kg; seated BP, 109.9 [9.0]/73.6 [9.5] mm Hg; seated HR, 63.8 [8.4] bpm) were randomized. No significant effects of midodrine on BP were observed. At Cmax, midodrine decreased norepinephrine from 188.4 (30.6) to 162.5 (29.8) pg/mL (P = 0.011) and HR from 57.2 (7.3) to 54.9 (6.6) bpm (P = 0.022). A significant correlation was found between DGM concentration and HR (varphi -0.61; P = 0.014). A DGM-related increase in plasma ANP (+29.6 [90.0] fmoL/mL) was observed. CONCLUSION: This study in healthy male volunteers found that midodrine has sympatholytic influences that are independent of BP but related to augmented venous return. SN - 0149-2918 UR - https://www.unboundmedicine.com/medline/citation/18840368/Pharmacokinetic_and_pharmacodynamic_effects_of_midodrine_on_blood_pressure_the_autonomic_nervous_system_and_plasma_natriuretic_peptides:_a_prospective_randomized_single_blind_two_period_crossover_placebo_controlled_study_ DB - PRIME DP - Unbound Medicine ER -